期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

非免疫因素性肾病的免疫发病机制

Immune Mediated Mechanism Underlying Nonimmune Renal Diseases
下载PDF
导出
摘要 非免疫因素性肾病是指由许多非免疫性因素导致的肾脏损害,且在临床上越来越常见,也是慢性肾脏疾病发生、发展过程中重要因素。本文就非免疫因素性肾病的细胞免疫发病机制进行总结,为此类肾病的免疫治疗提供依据。
作者 李晓忠 钟莉
机构地区 苏州大学附属儿童医院肾免疫科
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2007年第17期1281-1283,共3页 Journal of Applied Clinical Pediatrics
基金 国家自然科学基金项目资助(30271234) 江苏省卫生厅基金项目资助(H200520)
关键词 非免疫因素性肾病 细胞免疫 发病机制 儿童
分类号 R726.9 [医药卫生—儿科]
  • 相关文献

参考文献22

  • 1Rodriguez - hurbe B, Pons H, Herrera - Acosta J,et al. Role of immuno- competent cells in nonimmune renal diseases [ J ]. Kidney Int, 2001,59 (5) :1626 - 1640.
  • 2Tejera N, Gomez - Garre D, Lazaro A, et al. Persistent proteinuria up - regulates angiotensin Ⅱ type 2 receptor and induces apoptosis in proximal tubular cells [ J ]. Am J Pathol,2004,164 ( 5 ) : 1817 - 1826.
  • 3Mishra R, Emancipator SN, Miller C, et al. Adipos differentiation - related protein and regulators of lipid homeostasis identified by gene expression profiling in the murine db/db diabetic kidney[J]. Am J Physiol Renal Physio1,2004,286 ( 5 ) : F913 - F921.
  • 4Benigni A, Corna D, Zoja C, et al. Targeted deletion of angiotensin Ⅱ type 1A receptor does not protect mice from progressive nephropathy of overload proteinuria [ J ]. J Am Soc Nephrol, 2004, 15 ( 10 ) : 2666 - 2674
  • 5Basile DP, Fredrich K, Weihrauch D, et ul. Angiostatin and matrix metalloprotease expression following ischemic acute renal failure [ J ]. Am J Renal Physiol,2004,286 ( 5 ) : F893 - F902
  • 6Ysebaert DK,De Greef KE, Vereauteren SR ,et al. Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury[ J ]. Nephrol Dial Transplant,2000,15(10) :1562 - 1574.
  • 7Finne P,Reunanen A, Stenman S, et al. Incidence of end - stage renal disease in patients with type 1 diabetes [J]. JAMA, 2005,294 ( 14 ) : 1782 - 1787.
  • 8Johnson RJ, Segal MS, Srinivas T, et al.Essential hypertension, progressive renal disease, and uric acid : A pathogenetie link [ J ] ? J Am Soc Nephrol,2005,16(7) :1909 - 1919
  • 9Nakataui T, Asai T. Non - immunologic factor: Immuuosuppressive drug - induced nephrotoxicity [ J]. Hinyokika Kiyo,2002,48( 11 ) :699 -705.
  • 10Marshall RP,Gohlke P,Chambers RC,et al, Angiotensin Ⅱ and the fibroproliferative response to acute lung injury [ J ].Am J Physiol Lung Cell Mol Physiol,2004,286 ( 1 ) :L156 - L164.

二级参考文献20

  • 1刘必成,张建东.肾脏固有细胞在肾脏结构重塑中的作用研究进展[J].中华肾脏病杂志,2004,20(5):382-384. 被引量：7
  • 2Yuan HT, Yang SP, Woolf AS. Hypoxia up-regulates angiopoietin-2, a Tie-2 ligand, in mouse mesangial cells.Kidney Int, 2000, 58:1912-1919.
  • 3Ruiz-Ortega M, Ruperez M, Lorenzo O, et al. Angiotensin Ⅱ regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney Int, 2002, 82 Suppl:12-22.
  • 4Baud L, Ardaillou R. Reactive oxygen species:production and role in the kidney. Am J Physiol, 1986, 251 (5 Pt 2):F765-F776.
  • 5Grewal IS, Flavell RA. CD40 and CD154 in cell mediated immunity. Annu Rev Immunol, 1998, 16:111-135.
  • 6Kuchroo VK. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways:application to autoimmune disease therapy. Cell, 1995, 10:707-718.
  • 7Woltman AM, De Haij S, Boonstra JG, et al. Interleukin-17 and CD40-ligand synergistically enhance cytokine and chemokine production by renal epithelial cells. J Am Soc Nephrol, 2000,11:2044-2055.
  • 8Kaufman J, Graf BA, Leung EC, et al. Fibroblasts as sentinel cells:role of the CDcd40-CDcd40 ligand system in fibroblast activation and lung inflammation, and fibrosis. Chest, 2001,120(1 Suppl):S53-S55.
  • 9Yang J, Liu Y. Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J Am Soc Nephrol, 2002,13:96-107.
  • 10Niemann-Masanek U, Mueller A, Yard BA, et al. B7-1(CD80)and B7-2(CD86) expression in human tubular epithelial cells in vivo and in vitro. Nephron, 2002, 92:542-556.

共引文献4

实用儿科临床杂志
2007年 第17期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部